Author

Masaki Fujisawa

Institution: ASKA Pharmaceutical (Japan)

Observed institution: ASKA Pharmaceutical (Japan)

ORCID: 0009-0008-7696-7011

Observed ORCID: 0009-0008-7696-7011

OpenAlex ID: A5000689407

Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study

2021 · Tasuku Harada, Yutaka Osuga, et al. · Fertility and Sterility · 65

Rifaximin‐altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials

2018 · Takumi Kawaguchi, Fumitaka Suzuki, et al. · Hepatology Research · 36

Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey)

2023 · Kaori Koga, Motoko Fukui, et al. · Journal of obstetrics and gynaecology research · 20

Association between serum albumin and cognitive dysfunction in hepatic encephalopathy: An exploratory data analysis

2020 · Kosuke Kaji, Kiwamu Okita, et al. · JGH Open · 15

Lower levels of serum albumin are associated with impairment of cognitive function in cirrhotic patients with early-stage hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials of rifaximin in Japan

2020 · Kosuke Kaji, Kiwamu Okita, et al. · 3

Efficacy, safety, and pharmacokinetics of rifaximin in pediatric patients with hepatic encephalopathy in Japan: An open-label study

2026 · Hideaki Okajima, Masashi Tagawa, et al. · Hepatology Communications

Relugolix Combination Tablets in Healthy Japanese Premenopausal Women: Pharmacokinetics, Pharmacodynamics, and Safety Profile

2025 · Yutaka Osuga, Hiroyasu Hozumi, et al. · Reproductive Medicine and Biology

Works count: 7

Citation count: 139

H-index: 4

I10-index: 4